Saadah Omar I, Banaganapalli Babajan, Kamal Naglaa M, Sahly Ahmed N, Alsufyani Hadeel A, Mohammed Arif, Ahmad Aftab, Nasser Khalidah Khalid, Al-Aama Jumana Y, Shaik Noor Ahmad, Elango Ramu
Princess Al-Jawhara Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.
Pediatric Gastroenterology Unit, Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Front Pediatr. 2021 Apr 26;9:652011. doi: 10.3389/fped.2021.652011. eCollection 2021.
Alström syndrome (AS) is a very rare childhood disorder characterized by cardiomyopathy, progressive hearing loss and blindness. Inherited genetic variants of ALMS1 gene are the known molecular cause of this disease. The objective of this study was to characterize the genetic basis and understand the genotype-phenotype relationship in Saudi AS patients. Clinical phenotyping and whole-exome sequencing (WES) analysis were performed on six AS patients belonging to two unrelated consanguineous Saudi families. Sanger sequencing was performed to determine the mode of inheritance of ALMS1 variant in first-degree family relatives and also to ensure its rare prevalence in 100 healthy population controls. We identified that Alström patients from both the families were sharing a very rare ALMS1, 3'-splice site acceptor (c.11873-2 A>T) variant, which skips entire exon-19 and shortens the protein by 80 amino acids. This disease variant was inherited by AS patients in autosomal recessive mode and is not yet reported in any population-specific genetic databases. AS patients carrying this mutation showed heterogeneity in clinical presentations. Computational analysis of the mutant centroid structure of ALMS1 mRNA revealed that exon-19 skipping enlarges the hairpin loop and decreases the free energy, eventually affecting its folding pattern, stability, and function. Hence, we propose c.11873-2A as an AS causative potential founder mutation in Saudi Arabia because it is found in two families lacking a common lineage. We conclude that WES analysis potentially helps in clinical phenotyping, early diagnosis, and better clinical management of Alström patients showing variable clinical expressivity.
阿尔斯特伦综合征(AS)是一种非常罕见的儿童疾病,其特征为心肌病、进行性听力丧失和失明。ALMS1基因的遗传变异是已知的该疾病分子病因。本研究的目的是确定沙特AS患者的遗传基础并了解其基因型-表型关系。对来自两个不相关的沙特近亲家庭的6名AS患者进行了临床表型分析和全外显子组测序(WES)分析。进行桑格测序以确定ALMS1变异在一级家族亲属中的遗传模式,并确保其在100名健康人群对照中的罕见发生率。我们发现两个家族的阿尔斯特伦患者都共享一种非常罕见的ALMS1 3'-剪接受体(c.11873-2 A>T)变异,该变异跳过了整个外显子19,使蛋白质缩短了80个氨基酸。这种致病变异由AS患者以常染色体隐性模式遗传,尚未在任何特定人群的遗传数据库中报道。携带此突变的AS患者临床表现存在异质性。对ALMS1 mRNA突变质心结构的计算分析表明,外显子19跳过会扩大发夹环并降低自由能,最终影响其折叠模式、稳定性和功能。因此,我们提出c.11873-2A作为沙特阿拉伯AS潜在的致病始祖突变,因为它在两个没有共同谱系的家族中被发现。我们得出结论,WES分析可能有助于对表现出可变临床表达性的阿尔斯特伦患者进行临床表型分析、早期诊断和更好的临床管理。